Effect of statin therapy on the progression of coronary atherosclerosis (Q34400201)

1 August 2017

1 reference

30 January 2021

1 reference

title

Effect of statin therapy on the progression of coronary atherosclerosis (English)

1 reference

1 August 2017

main subject

coronary artery disease

1 reference

21 July 2020

1 reference

10 October 2019

1 reference

30 January 2021

1 reference

1 reference

Jinwei Tian

1

1 reference

1 August 2017

Xia Gu

2

1 reference

1 August 2017

Yanli Sun

3

1 reference

1 August 2017

Xiang Ban

4

1 reference

1 August 2017

Yun Xiao

5

1 reference

1 August 2017

Sining Hu

6

1 reference

1 August 2017

Bo Yu

7

1 reference

1 August 2017

language of work or name

1 reference

1 September 2012

10 references

BMC Cardiovascular Disorders

1 August 2017

14 March 2019

19 March 2019

22 March 2019

17 June 2019

2 October 2019

10 October 2019

8 July 2020

21 July 2020

30 January 2021

10 references

1 August 2017

14 March 2019

19 March 2019

22 March 2019

17 June 2019

2 October 2019

10 October 2019

8 July 2020

21 July 2020

30 January 2021

12

1 reference

1 August 2017

page(s)

70

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

copyright license

9 references

14 March 2019

19 March 2019

22 March 2019

17 June 2019

2 October 2019

10 October 2019

8 July 2020

21 July 2020

on focus list of Wikimedia project

30 January 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

The effects of statin and niacin on plaque stability, plaque regression, inflammation and oxidative stress in patients with mild to moderate coronary artery stenosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Pleiotropic effects of the HMG-CoA reductase inhibitors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Imaging of the unstable plaque: how far have we got?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Current status of vulnerable plaque detection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

[Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Recent advances in intracoronary imaging techniques: focus on optical coherence tomography

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Pharmacogenomics of cardiovascular pharmacology: molecular network analysis in pleiotropic effects of statin -- an experimental elucidation of the pharmacologic action from protein-protein interaction analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Effect of torcetrapib on the progression of coronary atherosclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Meta-analysis of the studies assessing temporal changes in coronary plaque volume using intravascular ultrasound.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Early time to benefit with intensive statin treatment: could it be the pleiotropic effects?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Pleiotropic effects of statins in atherosclerosis: role on endothelial function, inflammation and immunomodulation.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Coronary plaque classification with intravascular ultrasound radiofrequency data analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Coronary Plaque Disruption

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Meta-analysis in clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Myocardial infarction: ACE inhibitors for all? For ever?

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Atherosclerotic Plaque Vulnerability as an Explanation for the Increased Risk of Stroke in Elderly Undergoing Carotid Artery Stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

In vivo coronary plaque histology in patients with stable and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Association of monocyte subset counts with coronary fibrous cap thickness in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Pleiotropic effects: should statins be considered an essential component in the treatment of dyslipidemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3468364

Virtual Histology Evaluation of Atherosclerosis Regression During Atorvastatin and Ezetimibe Administration

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-12-70

Impact of HMG-CoA reductase inhibitors for non-treated coronary segments

21 January 2018

1 reference

12 December 2020

Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Coronary risk factors and plaque morphology in men with coronary disease who died suddenly

1 reference

12 December 2020

Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS

1 reference

12 December 2020

Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology

1 reference

12 December 2020

Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound

1 reference

12 December 2020

Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic Monkeys

1 reference

12 December 2020

High-Dose Atorvastatin Improves Hypercholesterolemic Coronary Endothelial Dysfunction Without Improving the Angiogenic Response

1 reference

12 December 2020

Clinical significance of statin pleiotropic effects: hypotheses versus evidence

1 reference

12 December 2020

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

1 reference

12 December 2020

Pathology of the vulnerable plaque

1 reference

12 December 2020

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1 reference

12 December 2020

Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease

1 reference

12 December 2020

Comparison of Effects of Rosuvastatin and Atorvastatin on Plaque Regression in Korean Patients With Untreated Intermediate Coronary Stenosis

1 reference

12 December 2020

Pleiotropic effects of statins on cardiovascular events in the Japanese Coronary Artery Disease study

1 reference

12 December 2020

Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits

1 reference

12 December 2020

Effect of two intensive statin regimens on progression of coronary disease

1 reference

12 December 2020

Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS

1 reference

12 December 2020

Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2261-12-70

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference